These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8504946)

  • 1. Carcinomas of the oral cavity and oropharynx. Curative treatment with preservation of function.
    Million RR
    Front Radiat Ther Oncol; 1993; 27():20-30. PubMed ID: 8504946
    [No Abstract]   [Full Text] [Related]  

  • 2. Intra-arterial chemoradiation for T3-4 oral cavity cancer: treatment outcomes in comparison to oropharyngeal and hypopharyngeal carcinoma.
    Doweck I; Robbins KT; Samant S; Vieira F
    World J Surg Oncol; 2008 Jan; 6():2. PubMed ID: 18194553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An update on squamous carcinoma of the oral cavity, oropharynx, and maxillary sinus.
    Lubek JE; Clayman L
    Oral Maxillofac Surg Clin North Am; 2012 May; 24(2):307-16, x. PubMed ID: 22341511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The practice guideline 'Carcinoma of the oral cavity and oropharynx'].
    Knegt PP; Keus RB; Roodenburg JL
    Ned Tijdschr Geneeskd; 2006 Jan; 150(2):83-8. PubMed ID: 16440562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Combination therapy in advanced oral mucosal carcinomas. A prospective study].
    Rink B
    Zahn Mund Kieferheilkd Zentralbl; 1986; 74(7):717-23. PubMed ID: 2950686
    [No Abstract]   [Full Text] [Related]  

  • 6. Survival evaluation of treatment modality in squamous cell carcinoma of the oral cavity and oropharynx.
    Pericot J; Escribà JM; Valdés A; Biosca MJ; Monner A; Castellsagué X; Galiana R; Piulachs P; Escutia E; Mari A
    J Craniomaxillofac Surg; 2000 Feb; 28(1):49-55. PubMed ID: 10851674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a new staging system for recurrent oral cavity and oropharyngeal squamous cell carcinoma.
    Lacy PD; Spitznagel EL; Piccirillo JF
    Cancer; 1999 Oct; 86(8):1387-95. PubMed ID: 10526264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Weight loss predicts mortality after recurrent oral cavity and oropharyngeal carcinomas.
    Nguyen TV; Yueh B
    Cancer; 2002 Aug; 95(3):553-62. PubMed ID: 12209747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flow cytometric analysis of primary and metastatic squamous cell carcinoma of the oral cavity and oropharynx.
    Syms CA; Eibling DE; McCoy JP; Barnes L; Emanuel B; Fowler C; Wagner R; Johnson JT
    Laryngoscope; 1995 Feb; 105(2):149-55. PubMed ID: 8544594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [High caloric parenteral nutrition in patients with mouth and oropharyngeal cancers--a clinical study].
    Klein C; Howaldt HP; Frenz M; Klein G
    Zentralbl Chir; 1994; 119(1):28-36. PubMed ID: 8147157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of a surgical method in combined and complex treatment of patients with squamous cell oral and oropharyngeal cancer].
    Vikhlianov IV; Shoĭket IaN; Lazarev AF
    Khirurgiia (Mosk); 2007; (1):55-8. PubMed ID: 17426691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multimodal intensification therapy for previously untreated advanced resectable squamous cell carcinoma of the oral cavity, oropharynx, or hypopharynx.
    Schuller DE; Grecula JC; Agrawal A; Rhoades CA; Orr DA; Young DC; Malone JP; Merz M
    Cancer; 2002 Jun; 94(12):3169-78. PubMed ID: 12115349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome prediction after surgery and chemoradiation of squamous cell carcinoma in the oral cavity, oropharynx, and hypopharynx: use of baseline perfusion CT microcirculatory parameters vs. tumor volume.
    Bisdas S; Nguyen SA; Anand SK; Glavina G; Day T; Rumboldt Z
    Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1313-8. PubMed ID: 18963541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapy study. Comparison of postoperative irradiation versus omission of irradiation in mouth cavity and supraglottic carcinomas].
    Bobtz F
    HNO; 1997 Mar; 45(3):160. PubMed ID: 9417441
    [No Abstract]   [Full Text] [Related]  

  • 15. The influence of lymph node metastasis in the treatment of squamous cell carcinoma of the oral cavity, oropharynx, larynx, and hypopharynx: N0 versus N+.
    Layland MK; Sessions DG; Lenox J
    Laryngoscope; 2005 Apr; 115(4):629-39. PubMed ID: 15805872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of speech outcomes following treatment of oral and oropharyngeal cancers.
    Dwivedi RC; Kazi RA; Agrawal N; Nutting CM; Clarke PM; Kerawala CJ; Rhys-Evans PH; Harrington KJ
    Cancer Treat Rev; 2009 Aug; 35(5):417-24. PubMed ID: 19481871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term results of a multimodal intensification regimen for previously untreated advanced resectable squamous cell cancer of the oral cavity, oropharynx, or hypopharynx.
    Ozer E; Grecula JC; Agrawal A; Rhoades CA; Young DC; Schuller DE
    Laryngoscope; 2006 Apr; 116(4):607-12. PubMed ID: 16585867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging the treated oral cavity and oropharynx.
    Wippold FJ
    Eur J Radiol; 2002 Nov; 44(2):96-107. PubMed ID: 12413678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive factors for distant metastasis from oral and oropharyngeal squamous cell carcinoma.
    Kowalski LP; Carvalho AL; Martins Priante AV; Magrin J
    Oral Oncol; 2005 May; 41(5):534-41. PubMed ID: 15878760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cancer of the oral cavity and oropharynx in patients under 40 years of age: clinical appearance and treatment results].
    Takahara T; Fujitani T; Inoue K; Osamu K; Furuya T; Hattori H
    Nihon Jibiinkoka Gakkai Kaiho; 1988 Feb; 91(2):204-9. PubMed ID: 3373371
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.